High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway

Liver cancer is the fourth leading cause of cancer-related death globally, accounting for approximately 800,000 deaths annually. Hepatocellular carcinoma (HCC) is the most common type of liver cancer, making up about 80% of cases. Liver fibrosis and its end-stage disease, cirrhosis, are major risk f...

Full description

Bibliographic Details
Main Authors: Hyuk Moon, Kyungjoo Cho, Sunyeong Shin, Do Young Kim, Kwang-Hyub Han, Simon Weonsang Ro
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/20/3/581
_version_ 1798045071633809408
author Hyuk Moon
Kyungjoo Cho
Sunyeong Shin
Do Young Kim
Kwang-Hyub Han
Simon Weonsang Ro
author_facet Hyuk Moon
Kyungjoo Cho
Sunyeong Shin
Do Young Kim
Kwang-Hyub Han
Simon Weonsang Ro
author_sort Hyuk Moon
collection DOAJ
description Liver cancer is the fourth leading cause of cancer-related death globally, accounting for approximately 800,000 deaths annually. Hepatocellular carcinoma (HCC) is the most common type of liver cancer, making up about 80% of cases. Liver fibrosis and its end-stage disease, cirrhosis, are major risk factors for HCC. A fibrotic liver typically shows persistent hepatocyte death and compensatory regeneration, chronic inflammation, and an increase in reactive oxygen species, which collaboratively create a tumor-promoting microenvironment via inducing genetic alterations and chromosomal instability, and activating various oncogenic molecular signaling pathways. In this article, we review recent advances in fields of liver fibrosis and carcinogenesis, and consider several molecular signaling pathways that promote hepato-carcinogenesis under the microenvironment of liver fibrosis. In particular, we pay attention to emerging roles of the Hippo-YAP/TAZ signaling pathway in stromal activation, hepatic fibrosis, and liver cancer.
first_indexed 2024-04-11T23:14:44Z
format Article
id doaj.art-cbde99f441c54eb1be98470ae7a2ee82
institution Directory Open Access Journal
issn 1422-0067
language English
last_indexed 2024-04-11T23:14:44Z
publishDate 2019-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-cbde99f441c54eb1be98470ae7a2ee822022-12-22T03:57:40ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-01-0120358110.3390/ijms20030581ijms20030581High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling PathwayHyuk Moon0Kyungjoo Cho1Sunyeong Shin2Do Young Kim3Kwang-Hyub Han4Simon Weonsang Ro5Yonsei Liver Center, Yonsei University College of Medicine, Seoul 03722, KoreaYonsei Liver Center, Yonsei University College of Medicine, Seoul 03722, KoreaYonsei Liver Center, Yonsei University College of Medicine, Seoul 03722, KoreaYonsei Liver Center, Yonsei University College of Medicine, Seoul 03722, KoreaYonsei Liver Center, Yonsei University College of Medicine, Seoul 03722, KoreaYonsei Liver Center, Yonsei University College of Medicine, Seoul 03722, KoreaLiver cancer is the fourth leading cause of cancer-related death globally, accounting for approximately 800,000 deaths annually. Hepatocellular carcinoma (HCC) is the most common type of liver cancer, making up about 80% of cases. Liver fibrosis and its end-stage disease, cirrhosis, are major risk factors for HCC. A fibrotic liver typically shows persistent hepatocyte death and compensatory regeneration, chronic inflammation, and an increase in reactive oxygen species, which collaboratively create a tumor-promoting microenvironment via inducing genetic alterations and chromosomal instability, and activating various oncogenic molecular signaling pathways. In this article, we review recent advances in fields of liver fibrosis and carcinogenesis, and consider several molecular signaling pathways that promote hepato-carcinogenesis under the microenvironment of liver fibrosis. In particular, we pay attention to emerging roles of the Hippo-YAP/TAZ signaling pathway in stromal activation, hepatic fibrosis, and liver cancer.https://www.mdpi.com/1422-0067/20/3/581hepatocellular carcinomacirrhosisregenerationinflammationcytokinesgenetic instabilityreactive oxygen species
spellingShingle Hyuk Moon
Kyungjoo Cho
Sunyeong Shin
Do Young Kim
Kwang-Hyub Han
Simon Weonsang Ro
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
International Journal of Molecular Sciences
hepatocellular carcinoma
cirrhosis
regeneration
inflammation
cytokines
genetic instability
reactive oxygen species
title High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
title_full High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
title_fullStr High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
title_full_unstemmed High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
title_short High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
title_sort high risk of hepatocellular carcinoma development in fibrotic liver role of the hippo yap taz signaling pathway
topic hepatocellular carcinoma
cirrhosis
regeneration
inflammation
cytokines
genetic instability
reactive oxygen species
url https://www.mdpi.com/1422-0067/20/3/581
work_keys_str_mv AT hyukmoon highriskofhepatocellularcarcinomadevelopmentinfibroticliverroleofthehippoyaptazsignalingpathway
AT kyungjoocho highriskofhepatocellularcarcinomadevelopmentinfibroticliverroleofthehippoyaptazsignalingpathway
AT sunyeongshin highriskofhepatocellularcarcinomadevelopmentinfibroticliverroleofthehippoyaptazsignalingpathway
AT doyoungkim highriskofhepatocellularcarcinomadevelopmentinfibroticliverroleofthehippoyaptazsignalingpathway
AT kwanghyubhan highriskofhepatocellularcarcinomadevelopmentinfibroticliverroleofthehippoyaptazsignalingpathway
AT simonweonsangro highriskofhepatocellularcarcinomadevelopmentinfibroticliverroleofthehippoyaptazsignalingpathway